Literature DB >> 1103726

Tetracycline resistance in Escherichia coli isolates from hospital patients.

S M Camiolo, M E Beck, A M Reynard.   

Abstract

Hospital isolates of Escherichia coli resistant to tetracycline (TC) were studied to identify mechanisms which regulate TC resistance levels and ability to transfer TC resistance. Antibiotic resistance patterns, resistance levels to TC, and ability to transfer TC resistance were determined for the isolates. Similar data were obtained for the transferable plasmids after transfer to several new host strains of E. coli. Of the 110 isolates, 50% were able to transfer TC resistance by conjugation. There was a nearly linear relationship between the minimum inhibitory concentration (MIC) of TC for the hospital strains and the percentage of strains at a given MIC that could transfer TC resistance. The strains that were simultaneously resistant to tetracycline, streptomycin, and ampicillin had relatively high MICs of TC and high ability to transfer TC resistance. These results and surveys of TC-resistant E. coli by others suggest that TC resistance levels and transmissibility may be influenced by other resistance markers. The isolates which did not transfer TC resistance by conjugation were tested for the presence of TC resistance plasmids by mobilization or by transformation with deoxyribonucleic acid from the isolates. Evidence for plasmid-mediated TC resistance was found in 92 (84%) of the 110 hospital strains.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1103726      PMCID: PMC429378          DOI: 10.1128/AAC.8.4.488

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  GENETIC RECOMBINATION BETWEEN THE RESISTANCE TRANSFER FACTOR AND THE CHROMOSOME OF ESCHIERICHIA COLI.

Authors:  H S GINOZA; R B PAINTER
Journal:  J Bacteriol       Date:  1964-06       Impact factor: 3.490

2.  DISAPPEARANCE OF OXYTETRACYCLINE ACCUMULATION IN THE CELLS OF MULTIPLE DRUG-RESISTANT ESCHERICHIA COLI.

Authors:  K IZAKI; K ARIMA
Journal:  Nature       Date:  1963-10-26       Impact factor: 49.962

3.  Infective heredity of multiple drug resistance in bacteria.

Authors:  T WATANABE
Journal:  Bacteriol Rev       Date:  1963-03

4.  Mutants of Escherichia coli requiring methionine or vitamin B12.

Authors:  B D DAVIS; E S MINGIOLI
Journal:  J Bacteriol       Date:  1950-07       Impact factor: 3.490

5.  The activity of different transfer factors introduced into the same plasmid-containing strain of Escherichia coli K12.

Authors:  H W Smith; E D Heller
Journal:  J Gen Microbiol       Date:  1973-09

6.  Bacteriological examination of rectal specimen during long-term oxytetracycline treatment for acne vulgaris.

Authors:  H Schmidt; E From; G Heydenreich
Journal:  Acta Derm Venereol       Date:  1973       Impact factor: 4.437

7.  Transferable drug resistance and other transferable agents in strains of Escherichia coli from two human populations.

Authors:  M J Lewis
Journal:  Lancet       Date:  1968-06-29       Impact factor: 79.321

8.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

9.  R-factor-mediated resistance to tetracycline in Proteus mirabilis.

Authors:  T J Franklin; R Rownd
Journal:  J Bacteriol       Date:  1973-07       Impact factor: 3.490

10.  R-factors of Escherichia coli from dressed beef and humans.

Authors:  G F Babcock; D L Berryhill; D H Marsh
Journal:  Appl Microbiol       Date:  1973-01
View more
  2 in total

1.  Effects of antibiotic resistance plasmids on the bactericidal activity of normal rabbit serum.

Authors:  A M Reynard; M E Beck; R K Cunningham
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

2.  Plasmid-mediated resistance to the bactericidal effects of normal rabbit serum.

Authors:  A M Reynard; M E Beck
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.